173 related articles for article (PubMed ID: 37067947)
1. Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients.
Noviello M; Lorentino F; Xue E; Racca S; Furnari G; Valtolina V; Campodonico E; Dvir R; Lupo-Stanghellini MT; Giglio F; Piemontese S; Clerici D; Oltolini C; Tassi E; Beretta V; Farina F; Mannina D; Ardemagni A; Vago L; Bernardi M; Corti C; Peccatori J; Clementi M; Ciceri F; Bonini C; Greco R
Blood Adv; 2023 Sep; 7(18):5446-5457. PubMed ID: 37067947
[TBL] [Abstract][Full Text] [Related]
2. HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.
Quintela A; Escuret V; Roux S; Bonnafous P; Gilis L; Barraco F; Labussière-Wallet H; Duscastelle-Leprêtre S; Nicolini FE; Thomas X; Chidiac C; Ferry T; Frobert E; Morisset S; Poitevin-Later F; Monneret G; Michallet M; Ader F;
J Infect; 2016 Feb; 72(2):214-22. PubMed ID: 26518057
[TBL] [Abstract][Full Text] [Related]
3. Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt.
Raouf MME; Ouf NM; Elsorady MAS; Ghoneim FM
Virol J; 2023 Feb; 20(1):20. PubMed ID: 36739398
[TBL] [Abstract][Full Text] [Related]
4. Human CD134 (OX40) expressed on T cells plays a key role for human herpesvirus 6B replication after allogeneic hematopoietic stem cell transplantation.
Nagamata S; Nagasaka M; Kawabata A; Kishimoto K; Hasegawa D; Kosaka Y; Mori T; Morioka I; Nishimura N; Iijima K; Yamada H; Kawamoto S; Yakushijin K; Matsuoka H; Mori Y
J Clin Virol; 2018 May; 102():50-55. PubMed ID: 29494951
[TBL] [Abstract][Full Text] [Related]
5. Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis.
Düver F; Weißbrich B; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
PLoS One; 2020; 15(2):e0228451. PubMed ID: 32017805
[TBL] [Abstract][Full Text] [Related]
6. High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality.
Winestone LE; Punn R; Tamaresis JS; Buckingham J; Pinsky BA; Waggoner JJ; Kharbanda S
Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29181879
[TBL] [Abstract][Full Text] [Related]
7. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
[TBL] [Abstract][Full Text] [Related]
8. [Prevalence of human herpesvirus-6 in allogeneic hematopoietic stem cell transplant recipients in correlation with cytomegalovirus infection].
Wang LR; Dong LJ; Lu DP
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1204-9. PubMed ID: 17204195
[TBL] [Abstract][Full Text] [Related]
9. Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation.
Vittayawacharin P; E'Leimat G; Lee BJ; Griffin S; Doh J; Nam H; Blodget E; Jeyakumar D; Kongtim P; Ciurea SO
Transplant Cell Ther; 2023 Jun; 29(6):397.e1-397.e6. PubMed ID: 36878429
[TBL] [Abstract][Full Text] [Related]
10. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
[TBL] [Abstract][Full Text] [Related]
11. Human Herpesvirus 6 Reactivation Evaluated by Digital Polymerase Chain Reaction and Its Association With Dynamics of CD134-Positive T Cells After Allogeneic Hematopoietic Stem Cell Transplantation.
Nakayama H; Yamazaki R; Kato J; Koda Y; Sakurai M; Abe R; Watanuki S; Sumiya C; Shiroshita K; Fujita S; Yamaguchi K; Okamoto S; Mori T
J Infect Dis; 2019 Aug; 220(6):1001-1007. PubMed ID: 31063196
[TBL] [Abstract][Full Text] [Related]
12. Human herpesvirus-6B infection in pediatric allogenic hematopoietic stem cell transplant patients: Risk factors and encephalitis.
Miura H; Kawamura Y; Hattori F; Tanaka M; Kudo K; Ihira M; Yatsuya H; Takahashi Y; Kojima S; Sakaguchi H; Yoshida N; Hama A; Yoshikawa T
Transpl Infect Dis; 2020 Feb; 22(1):e13203. PubMed ID: 31650671
[TBL] [Abstract][Full Text] [Related]
13. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.
Aoki J; Numata A; Yamamoto E; Fujii E; Tanaka M; Kanamori H
Biol Blood Marrow Transplant; 2015 Nov; 21(11):2017-22. PubMed ID: 26226409
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
[TBL] [Abstract][Full Text] [Related]
15. [Human herpesvirus 7 infection in patients after allogeneic hematopoietic stem cell transplantation].
Wang LR; Dong LJ; Lu DP
Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2113-6. PubMed ID: 17988530
[TBL] [Abstract][Full Text] [Related]
16. Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft-versus-host disease.
Han TT; Zhang YN; Sun YQ; Kong J; Wang FR; Wang ZD; Cheng YF; Yan CH; Wang Y; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XS
Transpl Infect Dis; 2021 Jun; 23(3):e13544. PubMed ID: 33326670
[TBL] [Abstract][Full Text] [Related]
17. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
Wang LR; Dong LJ; Zhang MJ; Lu DP
Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
[TBL] [Abstract][Full Text] [Related]
18. Human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation and class I human leukocyte antigen.
Yamamoto W; Ogusa E; Matsumoto K; Maruta A; Ishigatsubo Y; Kanamori H
Clin Transplant; 2014 May; 28(5):540-5. PubMed ID: 24579822
[TBL] [Abstract][Full Text] [Related]
19. Impact of Specific Antibody Level on Human Herpesvirus 6 Reactivation after Allogeneic Stem Cell Transplantation.
Nakayama H; Yamazaki R; Kato J; Koda Y; Sakurai M; Mori T
Transplant Cell Ther; 2021 Feb; 27(2):174.e1-174.e5. PubMed ID: 33830031
[TBL] [Abstract][Full Text] [Related]
20. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
